Al Hajj et al. fractionated breast cancer cells using flow cytometry and then through serial dilution assays demonstrated that the CD44+/CD24− CSC population showed an impressive 100-fold increased tumorigenicity compared to unfractionated cells [55]. The gene discussed is CD44; the disease is breast carcinoma.